J Korean Diabetes > Volume 19(1); 2018 > Article
The Journal of Korean Diabetes 2018;19(1):1-6.
DOI: https://doi.org/10.4093/jkd.2018.19.1.1    Published online April 13, 2018.
한국적 선샤인 액트(K-Sunshine Act): 경제적 이익 제공 내역에 관한 지출보고서 제출
이일권
K-Sunshine Act: Submission of an Expense Report on Details of Economic Interest.
Ilkweon Lee
Korean Diabetes Association Busan Ulsan Gyeongnam Branch Legal Adviser, Busan, Korea. ikelee08@gmail.com
Abstract
(1) A drug provider shall prepare an expense report on economic interests, etc. to be provided to pharmacists, oriental medicine pharmacists, medical personnel, medical institution founders, or persons working for a medical institution, within three months after the termination of each fiscal year, as prescribed by Ordinance of the Ministry of Health and Wealth, and shall retain the relevant expense report, books related thereto, and base data for five years. (2) Where deemed necessary, the Minister of Health and Wealth may request the submission of the expense report, books related thereto, and base data under paragraph (1). In such cases, a drug provider shall comply therewith without justifiable grounds.
Key Words: An expense report on economic interests, K-Sunshine Act
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 1,527 View
  • 11 Download
Related articles


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2024 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer